Lantheus Holdings, Inc. (NASDAQ:LNTH) Director David F. Burgstahler sold 230,685 shares of the company’s stock in a transaction that occurred on Thursday, August 31st. The shares were sold at an average price of $17.25, for a total value of $3,979,316.25. Following the completion of the sale, the director now owns 13,248 shares in the company, valued at approximately $228,528. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Shares of Lantheus Holdings, Inc. (LNTH) traded down 4.00% during midday trading on Friday, reaching $16.80. The company had a trading volume of 316,444 shares. The company’s 50 day moving average price is $17.68 and its 200 day moving average price is $14.99. The stock has a market capitalization of $627.48 million, a PE ratio of 22.95 and a beta of 0.91. Lantheus Holdings, Inc. has a 52-week low of $7.18 and a 52-week high of $20.45.

Lantheus Holdings (NASDAQ:LNTH) last released its quarterly earnings results on Tuesday, August 1st. The medical equipment provider reported $0.42 EPS for the quarter, topping the consensus estimate of $0.24 by $0.18. The company had revenue of $88.83 million for the quarter, compared to analyst estimates of $80.56 million. Lantheus Holdings had a negative return on equity of 37.47% and a net margin of 8.44%. The firm’s revenue was up 13.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.24 earnings per share. Equities research analysts expect that Lantheus Holdings, Inc. will post $1.12 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: “Lantheus Holdings, Inc. (LNTH) Director David F. Burgstahler Sells 230,685 Shares” was originally published by Watch List News and is owned by of Watch List News. If you are accessing this piece of content on another publication, it was stolen and republished in violation of US and international copyright and trademark laws. The correct version of this piece of content can be read at https://www.watchlistnews.com/lantheus-holdings-inc-lnth-director-david-f-burgstahler-sells-230685-shares/1536631.html.

A number of equities research analysts recently commented on LNTH shares. Cantor Fitzgerald started coverage on Lantheus Holdings in a research report on Monday, July 17th. They issued an “overweight” rating and a $22.00 target price on the stock. Zacks Investment Research upgraded Lantheus Holdings from a “hold” rating to a “strong-buy” rating and set a $17.00 target price on the stock in a research report on Thursday, May 4th. Credit Suisse Group upped their target price on Lantheus Holdings from $14.00 to $19.00 and gave the company a “neutral” rating in a research report on Wednesday, August 2nd. Jefferies Group LLC reiterated a “buy” rating and issued a $18.00 target price on shares of Lantheus Holdings in a research report on Friday, June 30th. Finally, BidaskClub lowered Lantheus Holdings from a “strong-buy” rating to a “buy” rating in a research report on Thursday, August 17th. One investment analyst has rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of $18.60.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in LNTH. State of Alaska Department of Revenue bought a new position in Lantheus Holdings during the second quarter worth about $102,000. Municipal Employees Retirement System of Michigan bought a new position in Lantheus Holdings during the second quarter worth about $107,000. LS Investment Advisors LLC bought a new position in Lantheus Holdings during the second quarter worth about $112,000. Quantbot Technologies LP bought a new position in Lantheus Holdings during the second quarter worth about $117,000. Finally, Teachers Retirement System of The State of Kentucky bought a new position in Lantheus Holdings during the second quarter worth about $141,000. 84.35% of the stock is currently owned by institutional investors.

Lantheus Holdings Company Profile

Lantheus Holdings, Inc is engaged in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its imaging agents and products are used across a range of imaging modalities, including echocardiography and nuclear imaging.

Insider Buying and Selling by Quarter for Lantheus Holdings (NASDAQ:LNTH)

Receive News & Ratings for Lantheus Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lantheus Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.